Search Results 251-260 of 3587 for asirvatham

  1. A Study to Learn More About the Eye (Intraocular Pressure, Ocular Hemodynamics) After Intravitreal Injections - Mayo Clinic

    The purpose of this study is to find out how much the eye pressure increases after giving the injection, and what happens to the blood supply of the various ...

  2. Post Approval Study of the CyPass System in Patients with Primary Glaucoma Undergoing Cataract Surgery - Mayo Clinic

    as determined at 36 months in patients with primary glaucoma undergoing cataract surgery. Participation eligibility. Participant eligibility includes age, ...

  3. A Study of Study of Free-Breathing Magnetic Resonance Elastography (MRE) of the Liver in Healthy Volunteers and Its Longitudinal Application in Patients with Chronic Liver Diseases - Mayo Clinic

    The purpose of this study is to implement a free-breathing hepatic MRE technique capable of being performed in as little as 0.8 seconds per slice which could ...

  4. A Study to Evaluate Whether Participants With Melanoma Prefer Subcutaneous vs Intravenous Administration of Nivolumab and Nivolumab + Relatlimab Fixed-dose Combinations - Mayo Clinic

    The purpose of this study is to assess the patient's preference for nivolumab subcutaneous (SC) or nivolumab + relatlimab fixed-dose combination (FDC) SC and ...

  5. Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Ribavirin in Treatment-Naïve HCV Genotype 1-Infected Adults With Chronic Kidney Disease - Mayo Clinic

    Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Ribavirin in Treatment-Naïve HCV Genotype 1-Infected Adults With Chronic Kidney Disease · Overview.

  6. Publications

    Publications. Sekar A, Griffin R, Parikh SA, Genovese G, Robinson DP, Norman AD, Olson JE, Rabe KG, Hoel MS, Boddicker NJ, Hampel PJ, Kay NE, Cerhan JR, ...

  7. A Study to Optimize Stroke Thrombolysis - Mayo Clinic

    About this study. The purpose of this study is to determine if argatroban (100µg/kg bolus followed by 3µg/kg per minute for 12 hours) or eptifibatide ...

  8. Continued Access to PREVAIL (CAP2) - Mayo Clinic

    About this study. To provide additional information about the safety and efficacy of the WATCHMAN LAA Closure Technology.

  9. Study of Selective BRAF Kinase Inhibitor Dabrafenib Monotherapy Twice Daily and in Combination with Dabrafenib Twice Daily and Trametinib Once Daily in Combination Therapy in Subjects With BRAF V600E Mutation Positive Metastatic (Stage IV) Non-small Cell Lung Cancer - Mayo Clinic

    Subjects will receive dabrafenib 150 mg twice daily (BID) in monotherapy treatment and dabrafenib 150 mg bid and trametinib 2 mg once daily in combination ...

  10. Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma - Mayo Clinic

    About this study. RATIONALE: Monoclonal antibodies, such as rituximab, can block cancer growth in different ways. Some find cancer cells and help kill them ...